503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
View analysts' price targets and recommendations, and compare them with competitors.
$601.38
Analysts expect the stock price to increase by 17.94%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
211.91B
Revenue has increased from the previous period.
6.88%
Revenue growth rate has decreased from the previous period.
105.14B
EBITDA has increased from the previous period.
49.61%
EBITDA margin has decreased from the previous period.
91.28B
EBIT has increased from the previous period.
43.07%
EBIT margin has decreased from the previous period.
13.86B
Depreciation has decreased from the previous period.
111.26B
Total cash has increased from the previous period.
52.50%
Cash percentage has decreased from the previous period.
48.69B
Receivables have increased from the previous period.
22.98%
Receivables percentage has increased from the previous period.
2.50B
Inventories have decreased from the previous period.
1.18%
Inventory percentage has decreased from the previous period.
18.09B
Accounts payable has decreased from the previous period.
8.54%
Payables percentage has decreased from the previous period.
-28.11B
Capital expenditure has increased from the previous period.
-13.26%
CapEx percentage has increased from the previous period.
8.38%
WACC has decreased from the previous period.
8.53%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
0.90
Beta is unchanged from the previous period.
7.47B
Diluted shares outstanding is unchanged from the previous period.
97.85B
Total debt is unchanged from the previous period.
3.37T
Total equity is unchanged from the previous period.
3.47T
Total capital is unchanged from the previous period.
2.82%
Debt weighting is unchanged from the previous period.
97.18%
Equity weighting is unchanged from the previous period.
73.96B
EBIAT has decreased from the previous period.
55.62B
UFCF has decreased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.24T
Terminal value is unchanged from the previous period.
2.58T
Enterprise value has increased from the previous period.
79.54B
Net debt is unchanged from the previous period.
2.50T
Equity value has increased from the previous period.
334.11
Equity value per share has increased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
24.15B
The estimated revenue has increased from the previous period.
9.48B
The estimated EBITDA has decreased from the previous period.
0.75
The estimated EPS has decreased from the previous period.
5.40B
The estimated net income has decreased from the previous period.
10.38B
The estimated EBIT has decreased from the previous period.
5.96B
The estimated SG&A expenses have increased from the previous period.
